We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$343M
AUM Growth
-$50.3M
Cap. Flow
-$56.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
78.35%
Holding
286
New
92
Increased
41
Reduced
68
Closed
66

Sector Composition

Rank Sector Weight
1 Real Estate 24.12%
2 Healthcare 12.62%
3 Financials 1.65%
4 Technology 1.41%
5 Industrials 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
226
Biogen
BIIB
$29.9B
-400
Closed -$113K
BIO icon
227
Bio-Rad Laboratories Class A
BIO
$8.42B
-106
Closed -$79K
BLUE
228
DELISTED
bluebird bio
BLUE
-2,470
Closed -$612K
CAG icon
229
Conagra Brands
CAG
$7.07B
-3,487
Closed -$118K
CHRS icon
230
Coherus Oncology
CHRS
$217M
-35,000
Closed -$562K
CNC icon
231
Centene
CNC
$31.3B
-2,070
Closed -$129K
CWB icon
232
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
-5,477
Closed -$467K
DGX icon
233
Quest Diagnostics
DGX
$25.1B
-995
Closed -$145K
DHR icon
234
Danaher
DHR
$135B
-296
Closed -$80K
DVA icon
235
DaVita
DVA
$15.1B
-1,408
Closed -$164K
EBAY icon
236
eBay
EBAY
$48.6B
-2,479
Closed -$173K
EMB icon
237
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
-2,847
Closed -$313K
EMHY icon
238
iShares JPMorgan EM High Yield Bond ETF
EMHY
$618M
-8,709
Closed -$386K
EPOL icon
239
iShares MSCI Poland ETF
EPOL
$669M
-5,078
Closed -$111K
EZA icon
240
iShares MSCI South Africa ETF
EZA
$525M
-2,147
Closed -$101K
GHYG icon
241
iShares US & Intl High Yield Corp Bond ETF
GHYG
$184M
-6,305
Closed -$316K
GILD icon
242
Gilead Sciences
GILD
$161B
-11,500
Closed -$803K
GREK
243
Global X MSCI Greece ETF
GREK
$288M
-4,034
Closed -$109K
GYRE icon
244
Gyre Therapeutics
GYRE
$662M
-15,200
Closed -$469K
HUM icon
245
Humana
HUM
$46.7B
-305
Closed -$119K
ICAD
246
DELISTED
iCAD Inc
ICAD
-40,000
Closed -$430K
IDXX icon
247
Idexx Laboratories
IDXX
$42.9B
-137
Closed -$85K
IGSB icon
248
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
-1,818
Closed -$99K
IMTX icon
249
Immatics
IMTX
$1.24B
-35,000
Closed -$455K
KR icon
250
Kroger
KR
$34.8B
-3,820
Closed -$154K

Similar funds

AlphaCentric Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, AlphaCentric Advisors held 286 positions worth $343M, down 13% from $393M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

AlphaCentric Advisors withdrew a net $56.3M in Q4 2021, closing 66 positions and reducing 68 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $1.86M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Jazz Pharmaceuticals worth $1.27M.

  • AlphaCentric Advisors's largest Q4 2021 buy was Jazz Pharmaceuticals: 10,000 shares worth $1.27M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2021, an estimated $1.84M increase.
  • AlphaCentric Advisors's biggest Q4 2021 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $30.4M.
  • AlphaCentric Advisors fully exited Vertex Pharmaceuticals in Q4 2021, selling an estimated $1.86M.
  • AlphaCentric Advisors's ten largest holdings make up 78% of its $343M portfolio in Q4 2021.
  • AlphaCentric Advisors opened 92 new positions and closed 66 in Q4 2021.
  • AlphaCentric Advisors's portfolio value fell 13% quarter-over-quarter to $343M.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.